Tumor cell-specific gene expression by 5'-flanking DNA of murine Q5 gene in an adenoviral vector system

Eri Kuwada1, Katsuo Noguchi, Kenji Hasezawa

  • 1Medinet Medical Institute, Medinet Co., Ltd., Setagaya-ku, Tokyo, Japan.

Anticancer Research
|May 30, 2008
PubMed
Abstract

Insights

Researchers identified tumor-selective regulatory DNA from mouse Q5 gene flanking regions. This DNA enables tumor cell-specific gene expression in both mouse and human cells, offering potential for cancer gene therapy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The search for regulatory DNA to drive tumor-specific gene expression in human cells is ongoing.
  • Previous studies indicated tumor-selective transcription of the mouse Q5 gene.
  • A hypothesis proposed that Q5 5'-flanking DNA plays a crucial role in this tumor selectivity.

Purpose of the Study:

  • To isolate and characterize the Q5 5'-flanking DNA.
  • To construct and test vector systems utilizing this DNA for tumor-specific gene expression.

Main Methods:

  • Isolation and sequencing of 3.9 kb Q5 5'-flanking DNA.
  • Construction of reporter plasmids, adenoviruses, and lentiviruses with varying lengths of Q5 5'-flanking DNA.
  • In vitro and in vivo expression analysis in murine and human cells.

Main Results:

  • The Q5 5'-flanking DNA contains a regulatory region.
  • Adenovirus vectors incorporating this DNA demonstrated tumor cell-specific gene expression.
  • This tumor selectivity was observed in both mouse and human cells.

Conclusions:

  • A novel vector system utilizing Q5 5'-flanking DNA has been developed.
  • This system effectively induces tumor cell-specific gene expression across species.
  • The findings suggest potential applications in gene therapy for human cancers.

Related Concept Videos